-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Dengue virus
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- Flavivirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Nipah virus
- Orthopoxvirus
- Others
- Rabies virus (RABV)
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Tobacco mosaic virus (TMV)
- Vesicular stomatitis virus (VSV)
- Virus Protease
- West Nile virus
- Antiviral intermediates
(Rac)-PD 135390
![{PARAM:[Name]}()](https://resource.bocsci.com/structure/150351-31-8.gif)
| Category | Virus Protease |
| CAS | 150351-31-8 |
| Description | PD 135390 has been found to be a HIV-1 protease inhibitor that could probably be effective against HIV infections. |
Product Information
| Synonyms | PD-135390; PD135390; PD 135390; 5-((2S)-N-(1-(allylthio)-2-amino-2-oxoethyl)-2-(morpholine-4-sulfonamido)-3-phenylpropanamido)-N-butyl-6-cyclohexyl-4-hydroxy-2-isopropylhexanamide |
| Molecular Weight | 752.04 |
| Molecular Formula | C37H61N5O7S2 |
| Canonical SMILES | O=C(C(NC(C(CC1=CC=CC=C1)NS(=O)(N2CCOCC2)=O)=O)SCC=C)NC(C(CC(C(C)C)C(NCCCC)=O)O)CC3CCCCC3 |
| InChI | InChI=1S/C37H61N5O7S2/c1-6-7-18-38-34(44)30(26(2)3)25-33(43)31(23-28-14-10-8-11-15-28)39-36(46)37(50-27(4)5)40-35(45)32(24-29-16-12-9-13-17-29)41-51(47,48)42-19-21-49-22-20-42/h9,12-13,16-17,26,28,30-33,37,41,43H,4,6-8,10-11,14-15,18-25H2,1-3,5H3,(H,38,44 |
| InChIKey | GFKAIQZIWHAOQP-UHFFFAOYSA-N |
| Purity | 98% |
| Appearance | Powder |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
